Initial trials of the potential vaccine could begin in April, but the process of testing and approvals would last at least a year.
The Wall Street Journal, which was first to report the development, said that two doses of the vaccine would be tested on up to 25 volunteers to see if it produces an immune response that protects against the virus. Fauci previously told CNN that researchers could expedite the approval process for a vaccine following a successful Phase 1 trial in an attempt to halt the spread of the virus.
While the experimental vaccine developed by Moderna remains unproven, the speed at which it was created represents a breakthrough.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오: